233 related articles for article (PubMed ID: 29661826)
1. Tumor Tolerance-Promoting Function of Regulatory T Cells Is Optimized by CD28, but Strictly Dependent on Calcineurin.
Marangoni F; Zhang R; Mani V; Thelen M; Ali Akbar NJ; Warner RD; Äijö T; Zappulli V; Martinez GJ; Turka LA; Mempel TR
J Immunol; 2018 May; 200(10):3647-3661. PubMed ID: 29661826
[TBL] [Abstract][Full Text] [Related]
2. Targeting CD28, CTLA-4 and PD-L1 costimulation differentially controls immune synapses and function of human regulatory and conventional T-cells.
Dilek N; Poirier N; Hulin P; Coulon F; Mary C; Ville S; Vie H; Clémenceau B; Blancho G; Vanhove B
PLoS One; 2013; 8(12):e83139. PubMed ID: 24376655
[TBL] [Abstract][Full Text] [Related]
3. Expansion of tumor-associated Treg cells upon disruption of a CTLA-4-dependent feedback loop.
Marangoni F; Zhakyp A; Corsini M; Geels SN; Carrizosa E; Thelen M; Mani V; Prüßmann JN; Warner RD; Ozga AJ; Di Pilato M; Othy S; Mempel TR
Cell; 2021 Jul; 184(15):3998-4015.e19. PubMed ID: 34157302
[TBL] [Abstract][Full Text] [Related]
4. Selective blockade of CD28 on human T cells facilitates regulation of alloimmune responses.
Zaitsu M; Issa F; Hester J; Vanhove B; Wood KJ
JCI Insight; 2017 Oct; 2(19):. PubMed ID: 28978798
[TBL] [Abstract][Full Text] [Related]
5. Construction of self-recognizing regulatory T cells from conventional T cells by controlling CTLA-4 and IL-2 expression.
Yamaguchi T; Kishi A; Osaki M; Morikawa H; Prieto-Martin P; Wing K; Saito T; Sakaguchi S
Proc Natl Acad Sci U S A; 2013 Jun; 110(23):E2116-25. PubMed ID: 23690575
[TBL] [Abstract][Full Text] [Related]
6. Immature dendritic cells convert anergic nonregulatory T cells into Foxp3- IL-10+ regulatory T cells by engaging CD28 and CTLA-4.
Pletinckx K; Vaeth M; Schneider T; Beyersdorf N; Hünig T; Berberich-Siebelt F; Lutz MB
Eur J Immunol; 2015 Feb; 45(2):480-91. PubMed ID: 25382658
[TBL] [Abstract][Full Text] [Related]
7. Graded Foxo1 activity in Treg cells differentiates tumour immunity from spontaneous autoimmunity.
Luo CT; Liao W; Dadi S; Toure A; Li MO
Nature; 2016 Jan; 529(7587):532-6. PubMed ID: 26789248
[TBL] [Abstract][Full Text] [Related]
8. B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis.
Liu Z; Geboes K; Hellings P; Maerten P; Heremans H; Vandenberghe P; Boon L; van Kooten P; Rutgeerts P; Ceuppens JL
J Immunol; 2001 Aug; 167(3):1830-8. PubMed ID: 11466409
[TBL] [Abstract][Full Text] [Related]
9. Effective proliferation of human regulatory T cells requires a strong costimulatory CD28 signal that cannot be substituted by IL-2.
Hombach AA; Kofler D; Hombach A; Rappl G; Abken H
J Immunol; 2007 Dec; 179(11):7924-31. PubMed ID: 18025240
[TBL] [Abstract][Full Text] [Related]
10. Donor-antigen Inoculation in the Testis Promotes Skin Allograft Acceptance Induced by Conventional Costimulatory Blockade via Induction of CD8 + CD122+ and CD4 + CD25+ Regulatory T Cells.
Cong L; Wang SF; Zhao ZL; Yang RY
Transplantation; 2016 Apr; 100(4):763-71. PubMed ID: 26569069
[TBL] [Abstract][Full Text] [Related]
11. Cutting edge: CD28 and c-Rel-dependent pathways initiate regulatory T cell development.
Vang KB; Yang J; Pagán AJ; Li LX; Wang J; Green JM; Beg AA; Farrar MA
J Immunol; 2010 Apr; 184(8):4074-7. PubMed ID: 20228198
[TBL] [Abstract][Full Text] [Related]
12. B Cells Drive Autoimmunity in Mice with CD28-Deficient Regulatory T Cells.
Zhang R; Sage PT; Finn K; Huynh A; Blazar BR; Marangoni F; Mempel TR; Sharpe AH; Turka LA
J Immunol; 2017 Dec; 199(12):3972-3980. PubMed ID: 29093061
[TBL] [Abstract][Full Text] [Related]
13. CD28 facilitates the generation of Foxp3(-) cytokine responsive regulatory T cell precursors.
Lio CW; Dodson LF; Deppong CM; Hsieh CS; Green JM
J Immunol; 2010 Jun; 184(11):6007-13. PubMed ID: 20421644
[TBL] [Abstract][Full Text] [Related]
14. Regulatory T Cell-Dependent and -Independent Mechanisms of Immune Suppression by CD28/B7 and CD40/CD40L Costimulation Blockade.
Vogel I; Verbinnen B; Van Gool S; Ceuppens JL
J Immunol; 2016 Jul; 197(2):533-40. PubMed ID: 27288533
[TBL] [Abstract][Full Text] [Related]
15. Regulatory Rebound in IL-12-Treated Tumors Is Driven by Uncommitted Peripheral Regulatory T Cells.
Li Q; Virtuoso LP; Anderson CD; Egilmez NK
J Immunol; 2015 Aug; 195(3):1293-300. PubMed ID: 26085681
[TBL] [Abstract][Full Text] [Related]
16. CTLA-4 is required for the induction of high dose oral tolerance.
Samoilova EB; Horton JL; Zhang H; Khoury SJ; Weiner HL; Chen Y
Int Immunol; 1998 Apr; 10(4):491-8. PubMed ID: 9620605
[TBL] [Abstract][Full Text] [Related]
17. Blockade of T cell activation using a surface-linked single-chain antibody to CTLA-4 (CD152).
Griffin MD; Hong DK; Holman PO; Lee KM; Whitters MJ; O'Herrin SM; Fallarino F; Collins M; Segal DM; Gajewski TF; Kranz DM; Bluestone JA
J Immunol; 2000 May; 164(9):4433-42. PubMed ID: 10779742
[TBL] [Abstract][Full Text] [Related]
18. ICOS Promotes the Function of CD4+ Effector T Cells during Anti-OX40-Mediated Tumor Rejection.
Metzger TC; Long H; Potluri S; Pertel T; Bailey-Bucktrout SL; Lin JC; Fu T; Sharma P; Allison JP; Feldman RM
Cancer Res; 2016 Jul; 76(13):3684-9. PubMed ID: 27197182
[TBL] [Abstract][Full Text] [Related]
19. Strength of TCR signal determines the costimulatory requirements for Th1 and Th2 CD4+ T cell differentiation.
Tao X; Constant S; Jorritsma P; Bottomly K
J Immunol; 1997 Dec; 159(12):5956-63. PubMed ID: 9550393
[TBL] [Abstract][Full Text] [Related]
20. Mouse and human CD8(+) CD28(low) regulatory T lymphocytes differentiate in the thymus.
Vuddamalay Y; Attia M; Vicente R; Pomié C; Enault G; Leobon B; Joffre O; Romagnoli P; van Meerwijk JP
Immunology; 2016 Jun; 148(2):187-96. PubMed ID: 26924728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
